Heat Biologics Inc.

AMEX: HTBX · Real-Time Price · USD
2.38
0.01 (0.42%)
At close: May 03, 2022, 6:00 AM

Heat Biologics Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-35.99M -35.4M -27.96M -29.38M -27.29M
Depreciation & Amortization
520.57K 415.27K 505.8K 416.32K 367.36K
Stock-Based Compensation
n/a n/a n/a n/a n/a
Other Working Capital
98.95M 103.76M 107.37M -1.88M -2.38M
Other Non-Cash Items
19.29M 18.55M 529.22K 496.73K 1.11M
Deferred Income Tax
n/a n/a n/a n/a n/a
Change in Working Capital
-18.31M -14.68M -10.96M -3.04M -3.61M
Operating Cash Flow
-32.1M -26.74M -33.18M -22.95M -21.09M
Capital Expenditures
-2.11M -1.38M -1.4M -3.77M -670.74K
Cash Acquisitions
n/a n/a n/a n/a n/a
Purchase of Investments
-28.57M -66.67M -77.56M -142.79M -144.1M
Sales Maturities Of Investments
46.2M 66.2M 68.74M 67.92M 45.04M
Other Investing Acitivies
n/a n/a n/a n/a 3.8M
Investing Cash Flow
15.51M -1.85M -10.21M -78.65M -95.93M
Debt Repayment
n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a
Other Financial Acitivies
-146.52K 25.55M 26.47M 102.49M 127.42M
Financial Cash Flow
-146.52K 25.55M 26.47M 102.49M 127.42M
Net Cash Flow
-16.74M -3.05M -16.93M 899.05K 10.42M
Free Cash Flow
-34.21M -28.12M -34.58M -26.72M -21.76M